On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Case description: August 11, 2009 first two visits
- Case description: August 17, third visit
- Dengue outbreak timeline
- Florida Keys trial
- Key Haven
- Oxitec’s genetically engineered mosquitoes
- The “silent expansion” of disease-causing vectors
- FDA review and “finding of no significant impact”
- Methods
- Findings (1)
- Ecological implications
- Human health (1)
- Human health (2)
- Genetically-modified organisms
- Mistrust of government
- Mistrust of industry
- Findings (2)
- Relationships among themes
- Georeferenced attitudes to GM mosquitoes
- Public response to GM mosquitoes trial
- Novel vector control methods deployed in California
- California attitudes and exposure to Ae. aegypti
- FDA publishes FONSI
- General election, November 8, 2016
- FKMCD approves agreement with Oxitec
- Ongoing use in other countries
- Final remarks
- Public health ethics
- Acknowledgements
Topics Covered
- Recent transmissions of mosquito-borne disease
- Oxitec proposal of a Florida Keys trial of genetically engineered mosquitoes
- FDA “Finding of No Significant Impact”
- FDA public comments analyzed
- Themes: ecological implications; human health; concerns about genetically modified organisms generally; government and industry mistrust
- Georeferenced attitudes to genetically engineered mosquitoes
- Results of Florida’s non-binding referendum
- Importance of public trust to successful public health interventions
Talk Citation
Bloss, C. (2018, April 30). Public response to a proposed field trial of genetically engineered mosquitoes in the United States [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/ZCPW6343.Export Citation (RIS)
Publication History
- Published on April 30, 2018
Financial Disclosures
- Prof. Cinnamon Bloss has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Public response to a proposed field trial of genetically engineered mosquitoes in the United States
Published on April 30, 2018
25 min
Other Talks in the Series: Gene-Drives and Active Genetics
Transcript
Please wait while the transcript is being prepared...
0:00
It's a pleasure to be able to present this work today.
My name is Cinnamon Bloss.
I am an Associate Professor at the University of California, San Diego.
The title of my talk is Public Response to
a Proposed Field Trial of Genetically Engineered Mosquitoes in the United States.
This is a case study analysis that I'll be speaking about today.
0:20
So, on August 11th,
2009 in Rochester, New York,
a 34-year-old female showed up at her primary care physician with a headache,
fever and was ended up being treated for a urinary tract infection.
Two days later, she still didn't feel right.
She came back to her physician with a worsening headache.
She had lightheadedness, retro orbital eye pain which is sort of a neurological red flag.
She ended up being referred to the emergency room
and at that time had a negative CAT scan and a lumbar puncture.
Over the course of her short stay in the emergency room,
her lightheadedness resolved and she was sent home after about a seven-hour stay there.
1:05
On August 17th, she came back again to her position for a third visit saying,
"I just don't feel right."
At that point, her physician learned that she
had just returned from a one-week trip to Key West,
Florida where she had received multiple mosquito bites.
At that point, an infectious disease specialist was brought in and
a serum test that they did at that time was sent to
the CDC and found to be positive for dengue fever.
1:35
So she was considered patient zero for
a dengue outbreak that occurred in Florida beginning at that time.
On August 31st, the second patient emerged,
a local Florida resident who is positive for dengue.
At that point, the Florida Department of Public Health did what's
called a serosurvey and randomly tested households in Florida.
Of about 240 people that were tested,
13 or about five percent had evidence of recent dengue infection.
In a number of months later,
by December of 2010,
there were a total of 88 confirmed cases of dengue associated with this outbreak.
This was the first instance of
dengue cases acquired in the continental United States outside of
the Texas-Mexico border since 1945 and
the first locally acquired cases in Florida since 1934.
Hide